Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Cirrhosis, Ascites Hepatic

In brief

A small, pilot proof-of-concept placebo-controlled trial to explore the effects of albumin on diuresis in patients with cirrhosis, ascites and lower extremity edema. We will additionally investigate albumin's effect on preventing neurohumoral activation, and acute kidney injury after diuresis.

Key facts

Study ID
NCT06812390
Run by
Anahita Rabiee MD MHS
People needed
20
Starts
2025-02-28
Expected to finish
2027-03-01
Last updated by the study team
2025-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.